Annals of Oncology · 2017 · 328 citations · 22 references
MedicineImmunologyOncologyImmunotherapyMetastasisTumor ImmunologyCancer ImmunotherapyCirculating Tumor CellsCirculating Tumor Dna AnalysisImmune Checkpoint InhibitorsImmuno-oncology BiomarkersMalignant NeoplasmsCirculating Tumor BiomarkersCirculating Tumor Cell BiomarkersCirculating Tumor Dna DetectionCirculating Tumor Dna DynamicsCirculating Tumor Dna SequencingCirculating Tumor Dna TestingCirculating Tumor Markers
22
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov, Serena Nik‐Zainal, David C. Wedge et al. · Nature · 2013 · 10.1K citations · Full text
Medicine, Cancer Biology, Oncology +14
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh, Christina L. Harview, Jennifer H. Yearley et al. · Nature · 2014 · 6.6K citations · Full text
Life Sciences, Immunology, Pathology +14
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert, Jacob Schachter, Georgina V. Long et al. · New England Journal of Medicine · 2015 · 5.8K citations · Full text